Ngm Biopharmaceuticals Inc SC 13G and SC 13G/A reports

Location
333 Oyster Point Boulevard, South San Francisco, CA
State of incorporation
DE
Fiscal year end
December 31
Data updated at
7/19/2024, 08:56 AM
Form type Sec Links Description Filing date Reporting date
SC 13G/A Report Feb 14, 2024
SC 13G/A Report SCHEDULE 13G/A Feb 13, 2024
SC 13G/A Report Oct 6, 2023
SC 13G/A Report Feb 13, 2023
SC 13G Report SCHEDULE 13G Feb 9, 2023
SC 13G Report Feb 3, 2023
SC 13G Report Oct 28, 2022
SC 13G/A Report Feb 16, 2021
SC 13G/A Report Feb 12, 2021
SC 13G/A Report SC 13G/A Nov 20, 2020
SC 13G Report Feb 11, 2020
SC 13G Report SC 13G Nov 26, 2019
SC 13G Report SC 13G Apr 9, 2019